Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Aura Biosciences, Inc. (AURA) Tops Q3 EPS by 6c
November 13, 2025 7:04 AM ESTAura Biosciences, Inc. (NASDAQ: AURA) reported Q3 EPS of ($0.40), $0.06 better than the analyst estimate of ($0.46).
For earnings history and earnings-related data on Aura Biosciences, Inc. (AURA) click here.
... More